| 000 | 01861 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250516085628.0 | ||
| 264 | 0 | _c20120719 | |
| 008 | 201207s 0 0 eng d | ||
| 022 | _a0027-5107 | ||
| 024 | 7 |
_a10.1016/j.mrgentox.2012.03.009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDoppalapudi, Rupa S | |
| 245 | 0 | 0 |
_aGenotoxicity of the cancer chemopreventive drug candidates CP-31398, SHetA2, and phospho-ibuprofen. _h[electronic resource] |
| 260 |
_bMutation research _cJul 2012 |
||
| 300 |
_a78-88 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticarcinogenic Agents _xtoxicity |
| 650 | 0 | 4 | _aCHO Cells |
| 650 | 0 | 4 |
_aChromans _xtoxicity |
| 650 | 0 | 4 | _aChromosome Aberrations |
| 650 | 0 | 4 | _aCricetinae |
| 650 | 0 | 4 | _aCricetulus |
| 650 | 0 | 4 |
_aDNA Damage _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIbuprofen _xanalogs & derivatives |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMicronucleus Tests |
| 650 | 0 | 4 |
_aMutagenicity Tests _xmethods |
| 650 | 0 | 4 |
_aMutagens _xtoxicity |
| 650 | 0 | 4 |
_aOrganophosphates _xtoxicity |
| 650 | 0 | 4 |
_aPyrimidines _xtoxicity |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred F344 |
| 650 | 0 | 4 |
_aSalmonella typhimurium _xgenetics |
| 650 | 0 | 4 |
_aThiones _xtoxicity |
| 700 | 1 | _aRiccio, Edward S | |
| 700 | 1 | _aDavis, Zoe | |
| 700 | 1 | _aMenda, Sean | |
| 700 | 1 | _aWang, Abraham | |
| 700 | 1 | _aDu, Nicholas | |
| 700 | 1 | _aGreen, Carol | |
| 700 | 1 | _aKopelovich, Levy | |
| 700 | 1 | _aRao, Chinthalapally V | |
| 700 | 1 | _aBenbrook, Doris M | |
| 700 | 1 | _aKapetanovic, Izet M | |
| 773 | 0 |
_tMutation research _gvol. 746 _gno. 1 _gp. 78-88 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.mrgentox.2012.03.009 _zAvailable from publisher's website |
| 999 |
_c21699531 _d21699531 |
||